Keyphrases
Chromatin
100%
Activity-dependent
100%
Polycomb Repressive Complex 2 (PRC2)
100%
Allosteric Activation
100%
Enhancer of Zeste Homolog 2 (EZH2)
27%
Activity in Vivo
18%
H3K27me3
18%
Clinical Trials
9%
Therapeutic Target
9%
Cancer Types
9%
Vulnerability
9%
In Cancer
9%
Hyperactivity
9%
Positive Feedback Loop
9%
Genetic Tools
9%
Gain-of-function
9%
Chemical Tools
9%
Feedback Mechanism
9%
Enzymatic Products
9%
Oncogenic mutations
9%
Chromatin Interactions
9%
EZH2 Inhibitor
9%
Anchorage Zone
9%
Aromatic Cage
9%
Weaver Syndrome
9%
Stepwise Mechanism
9%
Biochemistry, Genetics and Molecular Biology
PRC2
100%
EZH2
36%
EED
36%
Carcinogenesis
18%
Wild Type
9%
Genetics
9%
Clinical Trial
9%
Hyperactivity
9%